Hovione and iBET announce strategic collaboration
A strategic partnership that will take Hovione to new technology frontiers.
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
A strategic partnership that will take Hovione to new technology frontiers.
Hovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.
Hovione has achieved Top Employer certification across all four of its manufacturing sites worldwide for the fourth consecutive year.
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.
Investment in Hovione Tejo will expand industrial capacity and strengthen the company’s global leadership in spray drying and other advanced pharmaceutical manufacturing technologies.
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction
Hovione, the specialist integrated CDMO and the leader in spray drying and particle engineering, today announced it has acquired ExtremoChem Lda (ExtremoChem)
The new ConsiGma® CDC Flex delivers unprecedented flexibility, simplicity, and cost-efficiency in continuous direct compression.